首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized,double-blind,placebo-controlled,phase 3 study
Authors:Yutaka Seino  Takashi Sasaki  Atsushi Fukatsu  Michito Ubukata  Yoshishige Samukawa
Affiliation:1. Kansai Electric Power HospitalOsakaJapan;2. Division of Translational and Molecular Medicine, Research Center for Medical Sciences, The Jikei University School of MedicineTokyoJapan;3. Yachiyo HospitalAichiJapan;4. Taisho Pharmaceutical Co. LtdTokyoJapan
Abstract:
Keywords:Japanese  Luseogliflozin  Monotherapy  Phase 3 clinical study  Placebo-controlled  Sodium glucose cotransporter 2 inhibitor  Type 2 diabetes mellitus
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号